Hester Biosciences Limited (NSE:HESTERBIO)

Hester Biosciences Revenue

Hester Biosciences had revenue of 994.44M INR in the quarter ending September 30, 2026, with 40.12% growth. This brings the company's total for the last twelve months to 3.45B, up 14.51% year-over-year. In the fiscal year ending March 31, 2026, Hester Biosciences had annual revenue of 3.34B with 6.93% growth.

• Revenue (ttm): 3.45B
• Revenue Growth: +14.51%
• P/S Ratio: 5.64
• Revenue / Employee: 7.15M
• Employees: 483
• Market Cap: 19.75B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Poultry Healthcare 2.06B 61.9%
• Animal Healthcare 1.27B 38.1%

By Geography

Chart

• India 2.62B 78.8%
• outside India 706.28M 21.2%

Fiscal year ended Mar 31, 2026 See the full Hester Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.34B	216.47M	6.93%
Mar 31, 2025	3.12B	12.80M	0.41%
Mar 31, 2024	3.11B	329.89M	11.86%
Mar 31, 2023	2.78B	315.58M	12.79%
Mar 31, 2022	2.47B	289.51M	13.30%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error